The Oncology Issue
Cancer poses one of the greatest medical threats of our time. In this issue, you’ll hear from Bristol-Myers Squibb’s team of oncology experts regarding the company’s legacy of innovative research, its landmark collaborations and how patients stand to benefit from both.
Volume 2 | June 02, 2017
The I-O Quest
Exploring the research behind why some people respond to immunotherapy and others do not